Literature DB >> 23734699

Clinical findings and survival in cats naturally infected with feline immunodeficiency virus.

B P Liem1, N K Dhand, A E Pepper, V R Barrs, J A Beatty.   

Abstract

BACKGROUND: The clinical course and outcome of natural feline immunodeficiency virus (FIV) infection are variable and incompletely understood. Assigning clinical relevance to FIV infection in individual cats represents a considerable clinical challenge.
OBJECTIVE: To compare signalment, hematologic and biochemical data, major clinical problem, and survival among client-owned, FIV-infected, and uninfected domestic cats. ANIMALS: Client-owned, domestic cats tested for FIV (n = 520).
METHODS: Retrospective, case control study. Logistic regression analyses were conducted to identify risk factors for FIV infection and to compare hematologic and biochemical data between cases and controls, after adjusting for potential confounders. Survival times were compared using Kaplan-Meier curves.
RESULTS: The prevalence of FIV infection was 14.6%. Mixed breed, male sex, and older age were risk factors for FIV infection. Hematologic abnormalities, biochemical abnormalities or both were common in both FIV-infected and uninfected cats. Lymphoid malignancies were slightly more common in FIV-infected than uninfected cats. Survival of FIV-infected cats was not significantly different from that of uninfected cats. CONCLUSIONS AND CLINICAL IMPORTANCE: Multiple hematologic and biochemical abnormalities are common in old, sick cats regardless of their FIV status. Their presence should not be assumed to indicate clinical progression of FIV infection. A negative effect of FIV on survival was not apparent in this study.
Copyright © 2013 by the American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Clinicopathological findings; Feline immunodeficiency virus; Survival

Mesh:

Year:  2013        PMID: 23734699     DOI: 10.1111/jvim.12120

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

1.  Feline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.

Authors:  Justin Lee; Jennifer L Malmberg; Britta A Wood; Sahaja Hladky; Ryan Troyer; Melody Roelke; Mark Cunningham; Roy McBride; Winston Vickers; Walter Boyce; Erin Boydston; Laurel Serieys; Seth Riley; Kevin Crooks; Sue VandeWoude
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

2.  Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.

Authors:  Jonathan E Fogle; Lola Hudson; Andrea Thomson; Barbara Sherman; Margaret Gruen; B Duncan Lacelles; Brenda M Colby; Gillian Clary; Frank Longo; Rick B Meeker
Journal:  J Neurovirol       Date:  2021-03-04       Impact factor: 3.739

3.  Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Authors:  Paweł M Bęczkowski; Annette Litster; Tsang Long Lin; Dominic J Mellor; Brian J Willett; Margaret J Hosie
Journal:  Vet Microbiol       Date:  2015-01-03       Impact factor: 3.293

4.  Prevalence and risk factors of gammaherpesvirus infection in domestic cats in Central Europe.

Authors:  Reinhard Ertl; Melanie Korb; Ines Langbein-Detsch; Dieter Klein
Journal:  Virol J       Date:  2015-09-17       Impact factor: 4.099

5.  VetCompass Australia: A National Big Data Collection System for Veterinary Science.

Authors:  Paul McGreevy; Peter Thomson; Navneet K Dhand; David Raubenheimer; Sophie Masters; Caroline S Mansfield; Timothy Baldwin; Ricardo J Soares Magalhaes; Jacquie Rand; Peter Hill; Anne Peaston; James Gilkerson; Martin Combs; Shane Raidal; Peter Irwin; Peter Irons; Richard Squires; David Brodbelt; Jeremy Hammond
Journal:  Animals (Basel)       Date:  2017-09-26       Impact factor: 2.752

6.  Molecular Diagnosis of Felis catus Gammaherpesvirus 1 (FcaGHV1) Infection in Cats of Known Retrovirus Status with and without Lymphoma.

Authors:  Alicia J McLuckie; Vanessa R Barrs; Scott Lindsay; Mahdis Aghazadeh; Cheryl Sangster; Julia A Beatty
Journal:  Viruses       Date:  2018-03-14       Impact factor: 5.048

7.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.

Authors:  Carmen Ledesma-Feliciano; Sarah Hagen; Ryan Troyer; Xin Zheng; Esther Musselman; Dragana Slavkovic Lukic; Ann-Mareen Franke; Daniel Maeda; Jörg Zielonka; Carsten Münk; Guochao Wei; Sue VandeWoude; Martin Löchelt
Journal:  Retrovirology       Date:  2018-05-16       Impact factor: 4.602

9.  Transcriptome Analysis and In Situ Hybridization for FcaGHV1 in Feline Lymphoma.

Authors:  Mahdis Aghazadeh; Mang Shi; Patricia A Pesavento; Amy C Durham; Tamsen Polley; Shannon L Donahoe; Ryan M Troyer; Vanessa R Barrs; Edward C Holmes; Julia A Beatty
Journal:  Viruses       Date:  2018-08-30       Impact factor: 5.048

10.  Epidemiology and clinical outcomes of feline immunodeficiency virus and feline leukaemia virus in client-owned cats in New Zealand.

Authors:  Claire Luckman; M Carolyn Gates
Journal:  JFMS Open Rep       Date:  2017-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.